AB1956-I

Anti-phospho-VE-cadherin (Tyr731)

from rabbit, purified by affinity chromatography

• 别名: Cadherin-5, 7B4 antigen, Vascular endothelial cadherin, CD144
• 分類程式碼代碼: 12352203
• eCl@ss: 32160702
• NACRES: NA.41
• 無性繁殖: polyclonal
• application: WB; inhibition assay
• 物種活性: human
• 技術: inhibition assay: suitable (peptide); western blot: suitable

属性

• 生物源: rabbit
• 抗體表格: affinity isolated antibody
• 抗體產品種類: primary antibodies
• 無性繁殖: polyclonal
• 純化經由: affinity chromatography
• 物種活性: human
• 物種活性（以同源性預測）: mouse (based on 100% sequence homology)
• 技術: inhibition assay: suitable (peptide); western blot: suitable
• NCBI登錄號: NP_001786.2
• UniProt登錄號: P33151
• 目標翻譯後修改: phosphorylation (pTyr731)
• 基因資訊: human ... CDH5(1003)

说明

一般說明

Cadherin-5 (UniProt: P33151; also known as 7B4 antigen, Vascular endothelial cadherin, VE-cadherin, CD144) is encoded by the CDH5 gene (Gene ID: 1003) in human. Cadherins are calcium-dependent cell adhesion proteins, which preferentially interact with themselves in a homophilic manner in connecting cells. Cadherin 5 is a single-pass type I membrane protein that is found at cell-cell boundaries and may also be located at cell-matrix boundaries. It is well expressed in brain and endothelial tissue. It plays an important role in endothelial cell biology through control of the cohesion and organization of the intercellular junctions. It associates with alpha-catenin forming a link to the cytoskeleton. Cadherin 5 acts in concert with KRIT1 to establish and maintain correct endothelial cell polarity and vascular lumen. These effects are mediated by recruitment and activation of the Par polarity complex and RAP1B. Cadherin 5 is synthesized as a preproprotein with a signal peptide (aa 1-25) and propeptide (aa 26-47) that are proteolytically cleaved to produce the mature glycoprotein. It has an extracellular domain (aa 48-599), a short transmembrane domain (aa 600-620), and a cytoplasmic domain (aa 621-784) and contains five cadherin domains. Three calcium ions are usually bound at the interface of each cadherin domain and rigidify the connections, providing a strong curvature to the full-length ectodomains. Two isoforms of Cadherin 5 have been described that are produced by alternative splicing. Cadherin 5 can be phosphorylated on tyrosine residues by KDR/VRGFR-2. Phosphorylation at Tyr731 leads to the separation of beta-catenin from the cytoplasmic tail Cadherin 5. This phosphorylation event reported to be sufficient to maintain cells in a mesenchymal state during the cell invasion phase of angiogenesis.

特異性

This rabbit polyclonal antibody detects human and murine Cadherin-5 phosphorylated on Tyrosine 731.

免疫原

Epitope: C-terminus

KLH-conjugated linear peptide corresponding to 11 amino acids surrounding phosphorylated tyrosine 731 from human Cadherin-5.

應用

Anti-phospho-VE-cadherin (Tyr731), Cat. No. AB1965-I, is a rabbit polyclonal antibody that detects Cadherin-5 phosphorylated on Tyrosine 731 and has been tested for use in Western Blotting and Peptide Inhibition Assay.

Peptide Inhibition Analysis: A 1:1,500 dilution from a representative lot was used with HUVEC stimulated with VEGF for peptide block analysis.

Research Category
Cell Structure

品質

Evaluated by Western Blotting in lysate from HUVEC treated with VEGF.

Western Blotting Analysis: A 1:500 dilution of this antibody detected phospho-VE-cadherin (Tyr731) in lysate from HUVEC treated with VEGF.

標靶描述

~100 kDa observed; 87.53 kDa calculated. Uncharacterized bands may be observed in some lysate(s).

外觀

Affinity Purified

Purified rabbit polyclonal antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.

儲存和穩定性

Stable for 1 year at 2-8°C from date of receipt.

其他說明

Concentration: Please refer to lot specific datasheet.

免責聲明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.